Pharming Group (PHAR)
(Delayed Data from NSDQ)
$7.60 USD
-0.06 (-0.76%)
Updated Sep 24, 2024 12:44 PM ET
After-Market: $7.82 +0.22 (2.89%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PHAR 7.60 -0.06(-0.76%)
Will PHAR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PHAR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHAR
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
iTeos Therapeutics, Inc. (ITOS) Stock Jumps 5.4%: Will It Continue to Soar?
PHAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?
Strength Seen in Pharming Group N.V. Sponsored ADR (PHAR): Can Its 5.2% Jump Turn into More Strength?
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Other News for PHAR
Pharos Energy interim profit jumps as costs fall sharply
SMALL-CAP WINNERS & LOSERS: Pharos profit up; MJ Gleeson rises
Pharos Energy Advances Share Buyback Program
Pharos Energy Reports Strong Mid-Year Results
Pharos Energy Advances Buyback Program